SBI Securities’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10
Closed -$168 4092
2026
Q1
$168 Sell
10
-10
-50% -$179 ﹤0.01% 3279
2025
Q4
$321 Hold
20
﹤0.01% 3041
2025
Q3
$247 Buy
+20
New +$234 ﹤0.01% 3247

Other funds holding CLB

SBI Securities's CLB Position: Q2 2026 in Review

SBI Securities sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 10 shares — an estimated $168 sold.

SBI Securities first reported a position in CLB in Q3 2025 and held it in 3 quarters. The position peaked at $321 in Q4 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • SBI Securities reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • SBI Securities sold 10 Core Laboratories shares in Q2 2026, an estimated $168.
  • SBI Securities first reported a position in Core Laboratories in Q3 2025 and held it in 3 quarters.
  • SBI Securities's Core Laboratories position peaked at $321 in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.